Ministry Panel Split On Lifting Ban On Internet Sales Of Class I Drugs
This article was originally published in PharmAsia News
Japan may have decided to lift its ban on Internet sales of drugs, but its ministry responsible for doing so is having trouble writing the regulations to allow the sales to begin.
You may also be interested in...
Angelini is looking to take its recently-acquired ThermaCare brand to the next level by establishing a direct base in Germany to market the product and through a new distribution deal with Norway's Navamedic.
BD and BioMedomics have released a new rapid point-of-care test that can detect antibodies in blood to confirm current or past exposure to COVID-19.
Experts think GLP-1s in neurodegeneration may be Novo Nordisk’s next opportunity and await readouts from the Phase II ELAD trial in Alzheimer's disease for signals.